Information on applying for New Active Substance Work Sharing Initiative (NASWSI) and Biosimilar Work Sharing Initiative (BSWSI) assessments and list of approved products. The new hub will strengthen the MHRA’s work with regional partners and boost the UK’s digital health and life sciences sector. A list of authorised orphan medicinal products registered by the UK licensing authority. List of Field Safety Notices from 19 to 23 May 2025. The new hub will strengthen the MHRA’s work with regional partners and boost the UK’s digital health and life sciences sector. Department of Health and Social Care and MHRA register of licensed wholesale distribution sites (human and veterinary). List of sites granted a manufacturer or wholesale dealer licence. The MHRA register of licensed manufacturing sites: manufacturer specials - human (MS) and manufacturer specials authorisation - veterinary (MANSA) only. UK companies who have their licence to manufacture or wholesale medicines terminated and cancelled. Anyone who suspects that they’ve had an adverse reaction to their weight loss or diabetes medicine or suspects it is not a genuine product, should report it to the MHRA. GxP News
Access, new active substance and biosimilar work sharing initiatives
MHRA launches new digital hub in Leeds to drive innovation and regional growth
Decision: Orphan registered medicinal products
Field Safety Notices: 19 to 23 May 2025
MHRA launches new digital hub in Leeds to drive innovation and regional growth
Decision: Human and veterinary medicines: register of licensed wholesale distribution sites
Decision: Medicines: new manufacturing and wholesale dealer licences
Decision: Human and veterinary medicines: register of licensed manufacturing sites
Notice: Medicines: terminated and cancelled manufacturing and wholesale dealer licences
Women on “skinny jabs” must use effective contraception, MHRA urges in latest guidance
